Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer have?
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer has 1,227 citations in the OpenAlex counts ScholarIQ stores.
When was Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer published?
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer has 2012 year in the ScholarIQ index.
What is the open-access status of Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer?
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer has closed oa status in the ScholarIQ index.
What is the DOI of Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer?
The DOI for Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer is on the source record.
What is the PMID of Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer?
The PMID for Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer is on the source record.
What is the OpenAlex record for Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer?
The OpenAlex for Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer is on the source record.